Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$OGEN Either tomorrow 3/2 or 3/17..I called the company today to find out the exact date but never got a call back.
Only a matter of time. Patience will pay off here! Adding more next week for cheap!
In my opinion we will see soon a share price between $ 2 - $ 3 and with support from the government $ 10 or more!!!
I believe also very strong in a great future of ORAGENICS and also that we will get huge support from the government!!!
Well pre market i added to my position and bought 1.00 before that this week bought 1.07s also added. I hope i am right and we have to hold the dollar if so and with a good pr could see 1.80 or higher. I am a long term holder.
$OGEN IMO, The technicals are getting very interesting here. We have a cup n handle that has taken approx 7 months to form. It is possible that the completion of the handle is near. Could be today. This along with a possible earnings beat around the same time as completion of the handle would put a target of roughly 3.18. GLTA
$OGEN I feel like the cowboy who rode his horse over a cliff. On the way down he was pulling on the reigns and yelling whoa you sob, whoa! GLTA
I really hope but i also believe very strong that Oragenics will receive grants from the American government to expedite their unique vaccine development!!!
In my opinion, $ 10 is possible in the next 3 months, $ 20 in the next 6 months, and $ 100 or more in the next 3 years!!!!!!!!!!!!!
In my opinion, you can only buy and buy at these stock prices!!!!!!!!!
10 Bagger 2021 - Big support from J. B. (will move heaven and earth to fight against Corona-COVID-19-Mutations) and FDA!!!!!!!!!!!!!!
There is great hope in Oragenics!!!!!!!!!!!!!!!!
NOVAVAX - 1/20 $ 7 - 2/21 $ 290
ORAGENICS - 2/21 $ 1,34 - 2/22 $ ...
HUGE POTENTIAL and BIG SUPPORT from J. B. and FDA!!!
Maybe OGEN will be the highflyer 2021 and 2022!!!
Very interesting story!!!
$OGEN. A Director.
$OGEN The consensus is -.06 so a -.05+ is a win for us. I think they beat.
Lets hope its tomorrow. You think its going to be good?
$OGEN. Not so sure they’re due. I’ve seen 3 different dates. Tomorrow, 3/2 and 3/17.
Hope its good
Let's roll!
$OGEN Earnings tomorrow
I bought in. Call it a Covid play at that right time. With all the strains....these guys are going to get attention.
Short selling spiked in OGEN over the past couple of days.
https://nakedshortreport.com/company/OGEN
OGEN is up after hours.
If they could only have some news tomorrow and squeeze..
* * $OGEN Video Chart 02-09-2021 * *
Link to Video - click here to watch the technical chart video
Added 2500 shares today, will see what happens.
Yes, share are in short supply to cover with folks doing buy and hold these days. People are accumulating on the dips like crazy.
Rockying charlie, hit 1.98 this morning in the premarket. Looks like it will go over 2 today.
Better site easier to read.
short interest ogen
short interest
Shortvolume
20210208 OGEN
Short volume 28,031,607
Short Exempt Volume 273034
Total Volume 58010641
Wondering if there is a short position in this one.
* * $OGEN Video Chart 02-08-2021 * *
Link to Video - click here to watch the technical chart video
Got some more shares. FDA approval this will hit 20.
Major accumulation happening now. Very tempting to be a pig to accumulate more shares (50K or more).
Be sure to close any short positions right away. OGEN
OGEN will surprise a lot including me just starting. Some will sell out of impatience. Hold and add for big gains.
Price target is $2.50
wsj price target
I love what you just said could have another offering and than throw a bone mice /covid. If they did not throw the bone stock would had gone down big.
Added some first thing this morning. :)
lot of insider selling in dec ......prospectus after mkt close yesterday.....now they throw a bone on mice / covid.....
CAUTION....AND GLTA
Big news SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Demonstrates Protective Immunity in Mice
BUSINESS WIRE 6:00 AM ET 2/2/2021
* * $OGEN Video Chart 01-22-2021 * *
Link to Video - click here to watch the technical chart video
This comes back down to fill that gap in .80s I’ll join
32M $1.05 volume so far big move just starting
Followers
|
76
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
834
|
Created
|
01/29/13
|
Type
|
Free
|
Moderators |
President and Chief Executive Officer
Dr. Joslyn was a partner in Lazarus Pharmaceuticals. Prior to that he served as the Chief Executive Officer and Director of several privately held companies including Edusa Pharmaceuticals and Sentinella Pharmaceuticals and prior to that he was the Senior Vice-President Research and Development of Penwest Pharmaceuticals and also held senior drug development positions with Johnson & Johnson.
Chief Financial Officer
Mr. Sullivan has served as our interim principal executive officer since October 30, 2014 and served as our Chief Financial Officer, Secretary and Treasurer since February 6, 2012. Mr. Sullivan has held senior level financial positions for several publicly and privately held businesses including Utek Corporation, eANGLER, and HSN Direct International Limited. Most recently, he was the Group Financial Officer for the Investigative Services and Litigation Consulting Services segment of First Advantage Corporation. Mr. Sullivan is a Florida Certified Public Accountant. He graduated from the Florida State University with a Bachelor of Science in Accounting and a Master of Business Administration.
Senior Vice President of Discovery Research
Dr. Handfield is, the Company’s Senior Vice President of Discovery Research and previously has served as our Director of Research and Development. Prior to joining our Company, Dr. Handfield held a position as Tenured Associate Professor at the Center for Molecular Microbiology and the Department of Oral Biology at the University of Florida College of Dentistry, where he co-invented IVIAT and co-founded ivi Gene Corp. and Epicure Corp. to commercialize this and related technologies. Dr. Handfield holds a B.S. degree in Biochemistry, and a MS degree and PhD in Microbiology and Immunology from the Université Laval College of Medicine in Canada, and did postdoctoral training at the University of Florida.
January 7, 2021
December 29, 2020
December 24, 2020
November 24, 2020
November 20, 2020
November 19, 2020
October 6, 2020
September 28, 2020
September 11, 2020
August 20, 2020
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |